Clinical Trial Update: Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on using tenofovir in early pregnancy to prevent mother-to-child transmission of hepatitis B virus; phases completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tenofovir (Tenofovir)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED